Clinical relevance of neuroendocrine differentiation in non-small cell lung cancer assessed by immunohistochemistry: A retrospective study on 405 surgically resected cases

Virchows Archiv

Volumn 455, Issue 2, 2009, Pages 125-132

  Sterlacci, William ^a   Fiegl, Michael ^b   Hilbe, Wolfgang ^b   Auberger, Jutta ^b   Mikuz, Gregor ^a   Tzankov, Alexandar ^c  

^a MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Immunohistochemistry; Neuroendocrine differentiation; Non small cell lung cancer; Survival

Indexed keywords

ANTIBODY; ANTINEOPLASTIC AGENT; CHROMOGRANIN A; NERVE CELL ADHESION MOLECULE; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG ADENOSQUAMOUS CARCINOMA; LUNG LARGE CELL CARCINOMA; LUNG MUCOEPIDERMOID CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG PLEOMORPHIC CARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; OVERALL SURVIVAL; PATHOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TISSUE MICROARRAY; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CHROMOGRANIN A; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PROGNOSIS; RETROSPECTIVE STUDIES; SYNAPTOPHYSIN; TUMOR MARKERS, BIOLOGICAL; WORLD HEALTH ORGANIZATION;

EID: 69049097948     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0812-0     Document Type: Article

References (25)

1. F Kamangar GM Dores WF Anderson 2006 Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2137 2150
2. Parkin DM, Whelan SL, Ferlay J et al (2002) Cancer incidence in five continents, vol VIII. IARC, Lyon
3. Travis W, Brambilla E, Müller-Hermelink H et al (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC, Lyon
4. J Carles R Rosell A Ariza, et al. 1993 Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer Lung Cancer 10 209 219
5. JT Schleusener HD Tazelaar SH Jung, et al. 1996 Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma Cancer 77 1284 1291
6. A Gajra AH Tatum N Newman, et al. 2002 The predictive value of neuroendocrine markers and p53 for response to chemotherapy and survival in patients with advanced non-small cell lung cancer Lung Cancer 36 159 165
7. SL Graziano R Mazid N Newman, et al. 1989 The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer J Clin Oncol 7 1398 1406
8. C Carnaghi L Rimassa I Garassino, et al. 2001 Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer Ann Oncol 2 S119 S123
9. Y Segawa S Takata M Fujii, et al. 2009 Immunohistochemical detection of neuroendocrine differentiation in non-small-cell lung cancer and its clinical implications J Cancer Res Clin Oncol 135 1055 1059
10. MC Howe A Chapman K Kerr, et al. 2005 Neuroendocrine differentiation in non- small cell lung cancer and its relation to prognosis and therapy Histopathology 46 195 201
11. RL Attanoos 2000 Management of small biopsies in pulmonary disease CPD Bull, Cell Pathol 2 138 141
12. Fiegl M, Hilbe W, Auberger J, Schmid T et al (2008) Twelve-year retrospective analysis of lung cancer - the TYROL study: daily routine in 1,424 patients (1995-2006). J Clin Oncol 26, abstract 19063
13. W Hilbe K Aigner C Dittrich, et al. 2007 Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms Wien Klin Wochenschr 119 259 266
14. NJ Perkins EF Schisterman 2006 The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve Am J Epidemiol 163 670 675
15. DN Ionescu D Treaba CB Gilks, et al. 2007 Nonsmall cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance Am J Surg Pathol 31 26 32
16. G Pelosi F Pasini A Sonzogni, et al. 2003 Prognostic implications of neuroendocrine differentiation and hormone production in patients with stage I nonsmall cell lung carcinoma Cancer 97 2487 2497
17. M Petrovic I Tomic G Plavec, et al. 2008 Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer J BUON 13 93 96
18. A Tzankov P Went A Zimpfer, et al. 2005 Tissue microarray technology: principles, pitfalls and perspectives-lessons learned from hematological malignancies Exp Gerontol 40 737 744
19. RL Camp LA Charette DL Rimm 2000 Validation of tissue microarray technology in breast carcinoma Lab Invest 80 1943 1949
20. K Hiroshima A Iyoda K Shibuya, et al. 2002 Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung Ann Thorac Surg 73 1732 1735
21. A Baldi AM Groger V Esposito, et al. 2000 Neuroendocrine differentiation in non-small cell lung carcinomas In Vivo 14 109 114
22. G Rossi A Cavazza A Marchioni, et al. 2005 Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine carcinoma of the lung J Clin Oncol 23 8774 8785
23. H Takei H Asamura A Maeshima, et al. 2002 Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases J Thorac Cardiovasc Surg 124 285 292
24. AM Marchevsky AA Gal S Shah, et al. 2001 Morphometry confirms the presence of considerable nuclear size overlap between "small cells" and "large cells" in high-grade pulmonary neuroendocrine neoplasms Am J Clin Pathol 116 466 472
25. D Atkins KA Reiffen CL Tegtmeier, et al. 2004 Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections J Histochem Cytochem 52 893 901